Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Transrectal needle biopsy of the prostate required.
A clean-catch midstream-urine (MSU) culture negative (\<104 CFU/mL) for possible pathogens at the Pre-Therapy Visit prior to the TRNBP.
Gastrointestinal absorption is adequate as evidenced by passage of gas or feces per rectum and patient can tolerate oral food, fluids, and medication without vomiting or diarrhea.
You may not be if
History of hypersensitivity to ciprofloxacin or other quinolone antibiotics
Valvular heart disease that requires antibiotic prophylaxis to prevent bacterial endocarditis
Concomitant use of theophylline, probenecid, or warfarin at any time during the entire study
Renal insufficiency
Known or suspected central nervous system disorder that may predispose to seizures or lower the seizure threshold
Absolute neutrophil count (ANC) \<1000/mm3
Human immunodeficiency virus (HIV) infection with a CD4 count \<200 cells/micL. HIV testing is NOT required
Antibiotic administration within one week of the TRNBP
Severe hepatic insufficiency (Child-Pugh C)
Clareo Health | BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
